Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.78
+0.11002.36%
Post-market: 4.870.0900+1.88%19:33 EDT
Volume:545.05K
Turnover:2.59M
Market Cap:149.57M
PE:-1.16
High:4.84
Open:4.67
Low:4.58
Close:4.67
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.02
T/O Rate:2.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.68
PE(LYR):-1.68

Loading ...

Denali Therapeutics is Maintained at Buy by B. Riley Securities

Dow Jones
·
Yesterday

B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating

MT Newswires Live
·
Aug 25

BioXcel Therapeutics Amends Credit Agreement Amid Liquidity Strain

TIPRANKS
·
Aug 25

Knight Therapeutics Price Target Raised to C$11.50 at Raymond James

MT Newswires Live
·
Aug 25

Beam Therapeutics Price Target Maintained with a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 25

Neurizon Therapeutics files ASX governance disclosure for 2026

TIPRANKS
·
Aug 25

Prescient Therapeutics Launches Securities Purchase Plan for New Share Issue

TIPRANKS
·
Aug 25

Prescient Therapeutics Launches Share Purchase Plan to Raise Up to AU$7 Million, Shares Fall 7%

MT Newswires Live
·
Aug 25

Tempest Therapeutics Announces New Chief Financial Officer

TIPRANKS
·
Aug 25

Grace Therapeutics Files for Resale of Up to 4.8 Million Shares

MT Newswires Live
·
Aug 25

Grace Therapeutics files to sell 4.76M shares of common stock for holders

TIPRANKS
·
Aug 25

Press Release: Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer

Dow Jones
·
Aug 25

Lineage Cell Therapeutics management to meet with B. Riley

TIPRANKS
·
Aug 25

BioXcel Therapeutics Amends Credit Agreement, Extends Financing Deadline

TIPRANKS
·
Aug 24

Aquestive Therapeutics Price Target Maintained with a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 24

IMPACT Therapeutics to Join Hang Seng Composite Index

MT Newswires Live
·
Aug 24

Aptabio Therapeutics Partially Redeems and Cancels Private Convertible Bonds

TIPRANKS
·
Aug 24

ASX Flags Possible Delisting of Zelira Therapeutics Over Unpaid Listing Fees

TIPRANKS
·
Aug 24

Autolus Therapeutics Earnings Call Highlights Growth Momentum

TIPRANKS
·
Aug 23

Major Insider Move at CAMP4 Therapeutics Shakes Up Investor Buzz

TIPRANKS
·
Aug 22